TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 3 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -33.3% | 4,326 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -50.0% | 4,326 | +32.7% | 0.00% | – |
| Q2 2016 | $6,000 | -25.0% | 3,261 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -68.0% | 3,261 | 0.0% | 0.00% | – |
| Q4 2015 | $25,000 | +47.1% | 3,261 | 0.0% | 0.00% | – |
| Q3 2015 | $17,000 | -29.2% | 3,261 | +22.7% | 0.00% | – |
| Q2 2015 | $24,000 | +41.2% | 2,658 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | +70.0% | 2,658 | +50.9% | 0.00% | – |
| Q4 2014 | $10,000 | -16.7% | 1,761 | 0.0% | 0.00% | – |
| Q3 2014 | $12,000 | – | 1,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
| BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
| Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
| Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
| UBS AG | 1,878 | $19,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
| CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |